William Blair & Company’s AtriCure ATRC Stock Holding History
Bought
Maintained
Sold
Other funds holding ATRC
CIP
FLAM
N
William Blair & Company's ATRC Position: Q1 2024 in Review
William Blair & Company sold out of AtriCure (ATRC) in Q1 2024, closing a stake of 6,246 shares — an estimated $223K sold.
William Blair & Company first reported a position in ATRC in Q4 2015 and held it in 14 quarters. The position peaked at $1.94M in Q4 2016. 224 funds tracked by Wall St. Rank hold ATRC as of Q1 2024.
- William Blair & Company reported no remaining AtriCure position as of Q1 2024 after selling out during the quarter.
- William Blair & Company sold 6,246 AtriCure shares in Q1 2024, an estimated $223K.
- William Blair & Company first reported a position in AtriCure in Q4 2015 and held it in 14 quarters.
- William Blair & Company's AtriCure position peaked at $1.94M in Q4 2016.
- 224 funds tracked by Wall St. Rank held AtriCure as of Q1 2024.
Based on William Blair & Company's 13F filing for Q1 2024, filed 9 May 2024.